Sensex ends 4-day losing streak, Gains 581 pts, Nifty Above 16,000; Infosys, TCS Climbs 3% Each
Sensex ends 4-day losing streak, Gains 581 pts, Nifty Above 16,000; Infosys, TCS Climbs 3% Each
Today, investors will be closely watching the global developments around the Russia-Ukraine war and the US stance on any possible bans on Russia's oil and gas.

The key benchmark indices recovered sharply to end in the positive territory today amid high volatility led by the realty, IT, pharma names. At close, the Sensex was up 581.34 points or 1.10 per cent at 53,424.09, and the Nifty was up 150.30 points or 0.95 per cent at 16,013.50. About 2193 shares have advanced, 1069 shares declined, and 84 shares are unchanged.

IOC, Sun Pharma, Tata Consumer Products, Cipla and TCS were among the top Nifty gainers. On the other hand, Hindalco Industries, ONGC, Tata Steel, JSW Steel and Britannia Industries were the biggest losers. Among sectors, except metal all other sectoral indices ended in the green with pharma, IT, FMCG, capital goods and realty indices up 1-2 per cent. BSE midcap and smallcap indices rose over 1 per cent each.

The whole global market, including the Indian market, which sank dramatically in the past few trading sessions, ended its 4-day losing streak. This came despite the global markets exhibiting a mixed trend on the bourses and commodity prices, including Brent crude futures, staying at elevated levels.

Among individual shares, shares of city gas distribution (CGD) companies, Indraprastha Gas (IGL) and Mahanagar Gas (MGL), rallied up to 11 per cent in the intra-day trade on Tuesday amid reports of IGL announcing a hike in prices of compressed natural gas (CNG) in the Delhi-NCR region. The prices have been hiked by 50 paise per kilo in Delhi while Re 1 per kilo in the NCR region, as per reports.

Shares of sugar companies were in demand and rallied up to 18 per cent on the BSE in Tuesday’s intra-day trade on strong outlook. With a favourable mix of ethanol towards B-heavy/juice (feedstock) coupled with higher sugar realisations; operating margins of sugar companies are expected to improve.

Shares of Natco Pharma rallied 9 per cent to Rs 920 on the BSE in Tuesday’s intra-day trade after the company launched its first generic version of Revlimid (Lenalidomide capsules) in 5 mg, 10 mg, 15 mg, and 25 mg strengths in the US market. Natco, along with marketing partner Teva, has launching these strengths of lenalidomide.

Vinod Nair, Head of Research at Geojit Financial Services, said: “Domestic indices reversed its trend and traded with gains led by export-oriented sectors like Pharma and IT which witnessed buying interest as the rupee fell to its record lows. Favorable exit poll results of state election and low-level buying seen in mid and small caps also helped in adding optimism in the domestic market. Major western markets were also trading in the green while other Asian peers continued to trade in negative territory on fear of the impact of global inflationary pressure due to the ban on Russia’s oil export”

Read all the Latest Business News and Breaking News here

What's your reaction?

Comments

https://umatno.info/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!